Updated: Feb 25, 2021 18:25 IST
Pfizer, BioNTech begin testing of third dose against new COVID-19 variants
Washington [US], February 25 (ANI): Pfizer and its partner BioNTech on Thursday said that they have begun to test how well the third dose of their authorised vaccine stacks up against new coronavirus variants.
Read more
हिंदी खबर